These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24847998)

  • 1. Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report.
    Serra G; DE Chiara L; Koukopoulos AE; Koukopoulos A; Serra G; Kahn DA
    J Psychiatr Pract; 2014 May; 20(3):232-6. PubMed ID: 24847998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine in the treatment and prophylaxis of bipolar type II mood disorder and co-morbid eating disorder: a case report.
    De Chiara L; Serra G; Koukopoulos AE; Koukopoulos A; Serra G
    Riv Psichiatr; 2014; 49(4):192-4. PubMed ID: 25174697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimanic and long-lasting mood stabilizing effect of memantine in bipolar I mood disorder: two case reports.
    Serra G; De Chiara L; Koukopoulos A; Serra G
    J Clin Psychopharmacol; 2013 Oct; 33(5):715-7. PubMed ID: 24002206
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.
    Koukopoulos A; Reginaldi D; Serra G; Koukopoulos A; Sani G; Serra G
    Bipolar Disord; 2010 May; 12(3):348-9. PubMed ID: 20565444
    [No Abstract]   [Full Text] [Related]  

  • 5. The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial.
    Koukopoulos A; Serra G; Koukopoulos AE; Reginaldi D; Serra G
    J Affect Disord; 2012 Jan; 136(1-2):163-166. PubMed ID: 22030128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibromyalgia and bipolar disorder: a potential problem?
    Wilke WS; Gota CE; Muzina DJ
    Bipolar Disord; 2010 Aug; 12(5):514-20. PubMed ID: 20712752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder.
    Serra G; Koukopoulos A; De Chiara L; Koukopoulos AE; Tondo L; Girardi P; Baldessarini RJ; Serra G
    J Clin Psychiatry; 2015 Jan; 76(1):e91-7. PubMed ID: 25650685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and neurogenesis agent for treating bipolar II disorder: add-on memantine to mood stabilizer works.
    Lu RB; Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Tzeng NS; Lee IH; Chen PS; Yeh TL; Huang SY; Yang YK; Hong JS
    Med Hypotheses; 2012 Aug; 79(2):280-3. PubMed ID: 22677298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
    Keck PE; Hsu HA; Papadakis K; Russo J
    Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression.
    Ahn YM; Nam JY; Culver JL; Marsh WK; Bonner JC; Ketter TA
    Ann Clin Psychiatry; 2011 Feb; 23(1):17-24. PubMed ID: 21318192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing and treating comorbid (complicated) bipolar disorder.
    McElroy SL
    J Clin Psychiatry; 2004; 65 Suppl 15():35-44. PubMed ID: 15554795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipolar disorder: how far are we from a rigorous definition and effective management?
    Emilien G; Septien L; Brisard C; Corruble E; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):975-96. PubMed ID: 17459551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan for treatment of rapid-cycling bipolar disorder comorbid with fibromyalgia.
    Sharma V; Barrett C
    Can J Psychiatry; 2001 Jun; 46(5):452-3. PubMed ID: 11441787
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
    Chang JS; Moon E; Cha B; Ha K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.